VKTX Viking Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Lug 29, 2026
$29,94
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$26,89minimo 52 sett.
$43,15massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$3.49B
P/E (TTM)
-6.4
EPS (TTM)
$-4.67
Ricavi (TTM)
$0
i tuoi badge
Intervallo 52 sett.
$27–$43
Rating Analisti
BUY
Prezzo Obiettivo
$95
P/E
-6.4
ROE
-88.9%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
VKTX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$29.94
Capitalizzazione di Mercato (MRQ)
$3.49B
P/E (TTM)
-6.4
EPS (TTM)
$-4.67
Ricavi (TTM)
$0
ROE (TTM)
-88.9%
Intervallo 52 sett.
$27–$43
VKTX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$02016-12-31 → 2025-12-31
EPS$-3.192021-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | VKTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -6.4media 5 anni ≈-17.6 | ≈-17.6 | · | · | |
| P/B (MRQ) | 8.6media 5 anni ≈4.7 | ≈4.7 | 4.0 | Sopravvalutato | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -12.3media 5 anni ≈-22.8 | ≈-22.8 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 5.4media 5 anni ≈4.7 | ≈4.7 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | VKTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA (TTM) | -79.2%media 5 anni ≈-30.7% | ≈-30.7% | -17.4% | Debole | |
| ROE (TTM) | -88.9%media 5 anni ≈-32.9% | ≈-32.9% | -29.1% | Debole | |
| ROIC | -61.6% | · | -14.3% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | VKTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 4.7media 5 anni ≈18.6 | ≈18.6 | 9.0 | Bassa liquidità | |
| Quick Ratio | 2.2media 5 anni ≈2.1 | ≈2.1 | 4.0 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | VKTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | 0.3 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$0.00 | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-23.1%
Prossimo report
Ott 20, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Lug 21, 2026 | $-1.10 | $-1.27 | 13.5% |
| 31 Marzo 2026 | $-1.37 | $-1.03 | -32.5% | |
| 31 Dicembre 2025 | $-1.38 | $-0.91 | -51.3% | |
| 30 Settembre 2025 | $-0.81 | $-0.69 | -17.2% | |
| 30 Giugno 2025 | $-0.58 | $-0.46 | -27.4% | |
| 31 Marzo 2025 | $-0.41 | $-0.33 | -23.9% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $345M | $102M | $64M | $54M | $45M | $32M | $24M | $19M | $14M | $9M | $7M | $22M | |
| SG&A Expense | $48M | $49M | $37M | $16M | $11M | $11M | $9M | $7M | $5M | $5M | $5M | $1M | |
| Operating Expenses | $393M | $151M | $101M | $70M | $56M | $43M | $33M | $26M | $19M | $14M | $12M | $23M | |
| Operating Income | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | $-23M | |
| Other Non-op | $34M | $41M | $15M | $1M | $692.0K | $3M | $7M | $4M | $-2M | $-884.5K | $-11M | $2M | |
| Pretax Income | $-360M | $-110M | $-86M | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | $-22M | |
| EPS (Basic) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| EBITDA | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $27M | $56M | $37M | $26M | $29M | $8M | $25M | $9M | $3M | $768.5K | $755.9K | |
| Short-term Investments | · | · | · | · | · | $219M | $267M | $277M | $12M | $10M | $13M | · | |
| Prepaid Expense | $2M | $1M | $3M | $3M | $619.0K | $442.0K | $405.0K | $278.0K | $389.0K | $282.7K | $1M | $17.8K | |
| Current Assets | $716M | $907M | $367M | $167M | $211M | $256M | $284M | $302M | $22M | $14M | $15M | $773.7K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $775 | |
| Total Assets | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Accounts Payable | $53M | $10M | $8M | $9M | $1M | $4M | $2M | $959.0K | $2M | $1M | $592.4K | $2M | |
| Current Liabilities | $77M | $27M | $19M | $22M | $9M | $12M | $7M | $5M | $9M | $6M | $2M | $23M | |
| Capital Leases | $0 | $630.0K | $936.0K | $1M | · | $29.0K | $360.0K | · | · | · | · | · | |
| Total Liabilities | $77M | $28M | $20M | $23M | $9M | $12M | $7M | $5M | $9M | $6M | $7M | $25M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $358 | $208 | $97 | $60 | |
| Retained Earnings | $-848M | $-488M | $-378M | $-292M | $-223M | $-168M | $-129M | $-103M | $-81M | $-60M | $-46M | $-22M | |
| Treasury Stock | $0 | $0 | $7M | $7M | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $639M | $880M | $348M | $145M | $202M | $244M | $277M | $298M | $13M | $8M | $9M | $-22M | |
| Liabilities + Equity | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Shares Outstanding | 114,793,067 | 111,573,519 | 100,113,770 | 78,257,258 | 78,248,401 | 73,215,940 | 72,413,602 | 71,742,043 | 35,817,104 | 20,823,873 | 9,683,741 | 6,000,000 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $30M | $17M | $9M | $6M | $6M | $4M | $3M | $1M | $2M | $3M | $6.3K | |
| Operating Cash Flow | $-279M | $-88M | $-73M | $-48M | $-48M | $-22M | $-25M | $-19M | $-15M | $-11M | $-9M | $-2M | |
| Investing Cash Flow | $341M | $-553M | $-179M | $55M | $38M | $42M | $7M | $-266M | $-2M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $297M | $22M | $12M | $25M | · | |
| Stock Repurchased | · | · | · | $7M | · | · | · | · | · | $229 | $38 | $2 | |
| Net Stock Activity | · | · | · | $-7M | · | · | · | $297M | $22M | $12M | $25M | · | |
| Financing Cash Flow | $76M | $612M | $271M | $4M | $7M | $950.0K | $887.0K | $300M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | $11M | $-3M | $21M | $-16M | $16M | $6M | $2M | $12.7K | $576.2K |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -44.3% | -17.2% | -32.0% | -36.3% | -23.5% | -14.6% | -8.8% | -13.6% | -112.3% | -98.3% | -253.3% | · | |
| ROE | -47.3% | -17.9% | -34.8% | -39.7% | -24.6% | -15.2% | -9.0% | -14.2% | -191.3% | -175.7% | 349.2% | · | |
| ROIC | -61.6% | · | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 | 21.1 | 41.8 | 66.4 | 2.5 | 2.2 | 7.7 | · | |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 | 20.5 | 40.7 | 66.3 | 2.4 | 2.0 | 7.1 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.57 | $7.89 | $3.48 | $1.86 | $2.58 | $3.34 | $3.83 | $4.15 | $0.38 | $0.39 | $0.90 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.47 | $-0.81 | $-0.78 | $-0.63 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.44 | $0.24 | $0.55 | $0.47 | $0.34 | $0.40 | $0.12 | $0.35 | $0.25 | $0.15 | $0.08 | · | |
| EPS (TTM) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | · | |
| Market Cap | $4.04B | $4.49B | $1.86B | $736M | $360M | $412M | $581M | $549M | $145M | $25M | $33M | · | |
| P/E | -11.0 | -39.8 | -20.5 | -10.4 | -6.5 | · | · | · | · | · | · | · | |
| P/B | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | 2.1 | 1.8 | 10.8 | 3.1 | 3.8 | · | |
| P / Tangible Book | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -14.5 | -51.1 | -25.4 | -15.2 | -7.6 | -18.9 | -23.5 | -29.3 | -9.9 | -2.2 | -3.8 | · | |
| Earnings Yield | -9.1% | -2.5% | -4.9% | -9.6% | -15.4% | · | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $116M | $150M | $153M | $90M | $60M | $41M | $31M | $23M | $24M | $24M | $18M | $14M | $11M | $12M | $14M | $13M | |
| SG&A Expense | $17M | $14M | $11M | $9M | $14M | $14M | $15M | $14M | $10M | $10M | $9M | $10M | $10M | $4M | $4M | $4M | |
| Operating Expenses | $133M | $164M | $165M | $99M | $75M | $55M | $46M | $37M | $34M | $34M | $27M | $24M | $21M | $16M | $18M | $16M | |
| Operating Income | $-133M | $-164M | $-165M | $-99M | $-75M | $-55M | $-46M | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M | |
| Other Non-op | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $12M | $7M | $5M | $5M | $1M | $423.0K | $199.0K | $142.0K | |
| Net Income | $-128M | $-158M | $-158M | $-91M | $-66M | $-46M | $-35M | $-25M | $-22M | $-27M | $-23M | $-19M | $-20M | $-16M | $-17M | $-16M | |
| EPS (Basic) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| EPS (Diluted) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| Shares (Basic) | 116,263,000 | 115,568,000 | · | 112,320,000 | 112,134,000 | 112,069,000 | · | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| Shares (Diluted) | 116,263,000 | 115,568,000 | · | 112,320,000 | 112,134,000 | 112,069,000 | · | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| EBITDA | $-133M | $-164M | · | $-99M | $-75M | $-55M | · | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $118M | $166M | $100M | $34M | $38M | $27M | $50M | $44M | $196M | $37M | $70M | $18M | $29M | $16M | $12M | |
| Prepaid Expense | $941.0K | $1M | $2M | $2M | $3M | $865.0K | $1M | $2M | $138.0K | $643.0K | $670.0K | $960.0K | $4M | $956.0K | $1M | $388.0K | |
| Current Assets | $518M | $608M | $716M | $739M | $827M | $866M | $907M | $937M | $946M | $966M | $381M | $399M | $149M | $165M | $180M | $193M | |
| Total Assets | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Accounts Payable | $69M | $67M | $53M | $4M | $5M | $8M | $10M | $254.0K | $11M | $5M | $6M | $6M | $4M | $3M | $6M | $3M | |
| Current Liabilities | $110M | $106M | $77M | $26M | $32M | $20M | $27M | $26M | $25M | $33M | $13M | $13M | $16M | $14M | $15M | $11M | |
| Capital Leases | $4M | $0 | $0 | $318.0K | $410.0K | $502.0K | $630.0K | $755.0K | $766.0K | $852.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $114M | $106M | $77M | $26M | $32M | $20M | $28M | $26M | $26M | $34M | $14M | $15M | $17M | $15M | $16M | $13M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Retained Earnings | $-1.13B | $-1.01B | $-848M | $-690M | $-599M | $-534M | $-488M | $-452M | $-428M | $-405M | $-353M | $-331M | $-312M | $-272M | $-257M | $-239M | |
| Treasury Stock | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $7M | $7M | $5M | |
| Stockholders' Equity | $408M | $502M | $639M | $713M | $795M | $847M | $880M | $911M | $921M | $934M | $368M | $386M | $134M | $151M | $165M | $182M | |
| Liabilities + Equity | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Shares Outstanding | 116,652,937 | 115,893,943 | 114,793,067 | 112,446,961 | 112,329,709 | 112,288,759 | 111,573,519 | 111,434,821 | 110,796,200 | 110,228,869 | 100,028,828 | 100,028,828 | 79,319,081 | 76,688,478 | 76,688,478 | 77,373,712 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $10M | $9M | $7M | $14M | $11M | $6M | $9M | $7M | $8M | $4M | $5M | $4M | $2M | $2M | $2M | |
| Operating Cash Flow | $-125M | $-114M | $-85M | $-94M | $-47M | $-52M | $-31M | $-22M | $-29M | $-6M | $-20M | $-11M | $-25M | $-13M | $-13M | $-11M | |
| Investing Cash Flow | $109M | $54M | $76M | $160M | $43M | $63M | $7M | $26M | $-126M | $-460M | $-13M | $-204M | $2M | $27M | $19M | $2M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | |
| Financing Cash Flow | $24M | $12M | $75M | $480.0K | $507.0K | $349.0K | $1M | $3M | $3M | $606M | $-74.0K | $267M | $4M | $10.0K | $-2M | $-5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $51M | $-18M | $13M | $4M | $-14M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.0% | -21.5% | · | -10.8% | -7.4% | -5.0% | · | -3.8% | -3.3% | -4.9% | -8.2% | -6.6% | -11.3% | -8.1% | -8.3% | -7.2% | |
| ROE | -21.3% | -23.5% | · | -11.2% | -7.6% | -5.1% | · | -3.9% | -3.4% | -5.1% | -8.7% | -7.0% | -12.3% | -8.7% | -8.9% | -7.7% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 5.7 | · | 28.3 | 25.9 | 44.2 | · | 36.5 | 37.7 | 29.5 | 28.4 | 29.6 | 9.6 | 11.7 | 12.1 | 17.2 | |
| Quick Ratio | 1.1 | 1.1 | · | 3.9 | 1.1 | 1.9 | · | 2.0 | 1.8 | 6.0 | 2.8 | 5.2 | 1.2 | 2.1 | 1.1 | 1.1 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.50 | $4.33 | · | $6.34 | $7.08 | $7.54 | · | $8.18 | $8.31 | $8.47 | $3.68 | $3.86 | $1.69 | $1.97 | $2.15 | $2.36 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | |
| Cash Flow / Share | · | $-0.99 | · | · | · | $-0.47 | · | · | · | $-0.06 | · | · | $-0.31 | · | · | · | |
| Cash / Share | $1.08 | $1.02 | · | $0.89 | $0.30 | $0.34 | · | $0.45 | $0.40 | $1.77 | $0.37 | $0.69 | $0.23 | $0.38 | $0.21 | $0.16 | |
| EPS (TTM) | $-4.67 | $-4.15 | · | $-2.13 | $-1.54 | $-1.16 | · | $-0.92 | $-0.93 | $-0.92 | $-0.92 | $-0.90 | $-0.94 | $-0.81 | $-0.77 | $-0.74 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-535M | $-472M | · | $-237M | $-172M | $-128M | · | $-99M | $-97M | $-94M | $-81M | $-74M | $-72M | $-62M | $-59M | $-57M | |
| Market Cap | $4.55B | $3.77B | · | $2.96B | $2.98B | $2.71B | · | $7.05B | $5.87B | $9.04B | $1.11B | $1.62B | $1.32B | $209M | $222M | $232M | |
| P/E | -8.4 | -7.8 | · | -12.3 | -17.2 | -20.8 | · | -68.8 | -57.0 | -89.1 | -12.0 | -18.0 | -17.7 | -3.4 | -3.8 | -4.1 | |
| P/B | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Tangible Book | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Cash Flow | · | -33.1 | · | · | · | -51.8 | · | · | · | -1473.6 | · | · | -53.6 | · | · | -22.0 | |
| Earnings Yield | -12.0% | -12.8% | · | -8.1% | -5.8% | -4.8% | · | -1.5% | -1.8% | -1.1% | -8.3% | -5.5% | -5.7% | -29.8% | -26.6% | -24.7% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $0 | $0 | $0 | $0 | $0 |
| Utile netto | $-360M | $-110M | $-86M | $-69M | $-55M |
| EPS Diluito | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 |
Nessun dato per questo bilancio
Dati fondamentali insufficienti per creare questo bilancio al momento.
Proprietari istituzionali (13F) 499 filer · $3.8B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
499
Valore detenuto
$3.8B
Nuove posizioni
84
Posizioni chiuse
44
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 84 (+8 vs trimestre precedente) | 44 (-25 vs trimestre precedente) | 153 (-5 vs trimestre precedente) | 133 (+4 vs trimestre precedente) | +5.8M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $351.254.252 | 9.984.487 | 9,30% | Azioni |
| FMR LLC | $247.157.830 | 6.335.756 | 6,54% | Azioni |
| BlackRock, Inc. | $241.458.213 | 6.189.649 | 6,39% | Azioni |
| STATE STREET CORP | $218.705.430 | 5.606.394 | 5,79% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $197.143.394 | 5.053.663 | 5,22% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $174.931.100 | 4.484.263 | 4,63% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $153.598.520 | 3.937.414 | 4,07% | Azioni |
| MORGAN STANLEY | $135.990.439 | 3.486.040 | 3,60% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $113.382.565 | 2.906.500 | 3,00% | Opzione Call |
| AMERIPRISE FINANCIAL INC | $84.108.797 | 2.156.083 | 2,23% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $81.865.360 | 2.097.981 | 2,17% | Azioni |
| TWO SIGMA ADVISERS, LP | $74.906.241 | 2.129.228 | 1,98% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $70.844.186 | 1.816.050 | 1,88% | Azioni |
| D. E. Shaw & Co., Inc. | $62.649.826 | 1.605.994 | 1,66% | Azioni |
| DIADEMA PARTNERS LP | $47.623.408 | 1.220.800 | 1,26% | Opzione Call |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46.039.602 | 1.180.200 | 1,22% | Opzione Put |
| CITADEL ADVISORS LLC | $43.773.121 | 1.122.100 | 1,16% | Opzione Call |
| BNP PARIBAS FINANCIAL MARKETS | $38.296.117 | 981.700 | 1,01% | Azioni |
| CITADEL ADVISORS LLC | $37.118.600 | 951.515 | 0,98% | Azioni |
| GOLDMAN SACHS GROUP INC | $36.780.227 | 942.841 | 0,97% | Azioni |
| UBS Group AG | $36.515.505 | 936.055 | 0,97% | Azioni |
| JPMORGAN CHASE & CO | $36.387.793 | 915.185 | 0,96% | Azioni |
| JANE STREET GROUP, LLC | $35.091.757 | 899.558 | 0,93% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $31.846.477 | 816.367 | 0,84% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $30.999.667 | 794.660 | 0,82% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $28.557.153 | 732.047 | 0,76% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28.504.217 | 730.690 | 0,75% | Azioni |
| Pictet Asset Management Holding SA | $26.640.280 | 682.909 | 0,71% | Azioni |
| Vestal Point Capital, LP | $26.526.800 | 680.000 | 0,70% | Azioni |
| NORTHERN TRUST CORP | $24.448.309 | 626.719 | 0,65% | Azioni |
| CITADEL ADVISORS LLC | $23.530.832 | 603.200 | 0,62% | Opzione Put |
| Eversept Partners, LP | $23.519.987 | 602.922 | 0,62% | Azioni |
| BlackBarn Capital Partners LP | $23.406.000 | 600.000 | 0,62% | Azioni |
| Jump Financial, LLC | $22.621.196 | 579.882 | 0,60% | Azioni |
| ADAR1 Capital Management, LLC | $22.393.222 | 574.038 | 0,59% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $21.067.468 | 540.053 | 0,56% | Azioni |
| JANE STREET GROUP, LLC | $20.870.350 | 535.000 | 0,55% | Opzione Call |
| Connor, Clark & Lunn Investment Management Ltd. | $20.698.979 | 530.607 | 0,55% | Azioni |
| Caption Management, LLC | $20.511.458 | 525.800 | 0,54% | Opzione Call |
| TANG CAPITAL MANAGEMENT LLC | $19.505.000 | 500.000 | 0,52% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $19.433.690 | 498.172 | 0,51% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $19.290.796 | 494.509 | 0,51% | Azioni |
| Point72 Asset Management, L.P. | $18.463.745 | 473.308 | 0,49% | Azioni |
| Clearbridge Investments, LLC | $17.350.907 | 444.781 | 0,46% | Azioni |
| DIADEMA PARTNERS LP | $17.234.930 | 441.808 | 0,46% | Azioni |
| BLAIR WILLIAM & CO/IL | $16.258.035 | 416.766 | 0,43% | Azioni |
| Bank of New York Mellon Corp | $15.909.848 | 407.840 | 0,42% | Azioni |
| ExodusPoint Capital Management, LP | $15.346.650 | 393.000 | 0,41% | Opzione Call |
| BANK OF AMERICA CORP /DE/ | $14.971.064 | 383.775 | 0,40% | Azioni |
| Walleye Trading LLC | $14.964.236 | 383.600 | 0,40% | Opzione Call |
Insider aziendali 17 insider · 9 dirigenti · 8 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Brian Lian | President & CEO | 29 Luglio 2026 S | 2.572.441 | 0 | 6 | $-14.005.897 |
| Greg Zante | Chief Financial Officer | 29 Luglio 2026 S | 212.204 | 0 | 6 | $-2.823.737 |
| Marianna Mancini | Chief Operating Officer | 29 Luglio 2026 S | 422.760 | 0 | 6 | $-2.727.473 |
| Michael Dinerman | Chief Operating Officer | 04 Maggio 2015 C | 694.116 | 0 | 0 | $0 |
| Hubert C Chen | Chief Medical Officer | 01 Giugno 2026 A | · | 0 | 0 | $0 |
| Neil William Aubuchon | Chief Commercial Officer | 10 Marzo 2026 P | 4.475 | 1 | 0 | $149.912 |
| Michael Morneau | VP, Finance and Administration | 19 Gennaio 2021 F | 116.062 | 0 | 0 | $0 |
| Hiroko Masamune | Chief Development Officer | 03 Gennaio 2019 A | 141.063 | 0 | 0 | $0 |
| Rochelle Hanley | Chief Medical Officer | 04 Maggio 2016 F | 160.836 | 0 | 0 | $0 |
| Dorothy Elizabeth Kelly-Gemmell | Direttore | 01 Agosto 2026 A | 6.333 | 0 | 0 | $0 |
| Sarah Kathryn Rouan | Direttore | 02 Gennaio 2026 A | 4.390 | 0 | 0 | $0 |
| Lawson Macartney | Direttore | 02 Gennaio 2026 A | 51.115 | 0 | 0 | $0 |
| Charles A Rowland Jr | Direttore | 02 Gennaio 2026 A | 33.150 | 0 | 1 | $-2.134.200 |
| Matthew J Singleton | Direttore | 02 Gennaio 2026 A | 12.650 | 0 | 0 | $0 |
| Matthew W Foehr | Direttore | 02 Gennaio 2026 A | 135.186 | 0 | 1 | $-561.760 |
| Stephen W Webster | Direttore | 02 Gennaio 2020 A | 8.000 | 0 | 0 | $0 |
| Ligand Pharmaceuticals Incorporated | Proprietario del 10% | 26 Agosto 2020 S | 5.819.383 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 45 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| LABU · Direxion Shares ETF Trust | 0,78% | 121.599 NS | 31 Luglio 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,74% | 10.811 NS | 31 Luglio 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 3.463 NS | 31 Luglio 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,22% | 1.661 NS | 31 Luglio 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,15% | 4.217 NS | 31 Luglio 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,15% | 69.539 NS | 31 Luglio 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 29.780 NS | 31 Luglio 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,12% | 1.464.336 SH | 19 Agosto 2026 | Giornaliero |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 23.527 SH | 02 Ottobre 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,06% | 330.703 SH | 19 Agosto 2026 | Giornaliero |
| IYH · iShares Trust | 0,06% | 66.102 SH | 11 Settembre 2026 | Giornaliero |
| ESML · iShares Trust | 0,06% | 50.114 SH | 11 Settembre 2026 | Giornaliero |
| ISCG · iShares Trust | 0,05% | 16.143 SH | 11 Settembre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 52.319 NS | 31 Luglio 2026 | N-PORT |
| SMMD · iShares Trust | 0,05% | 60.016 SH | 11 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 1.332.828 SH | 19 Agosto 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,05% | 2.530.231 SH | 19 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 37.316 SH | 02 Ottobre 2026 | Giornaliero |
| IWS · iShares Trust | 0,03% | 156.686 SH | 11 Settembre 2026 | Giornaliero |
| WSML · iShares Trust | 0,03% | 6.550 SH | 11 Settembre 2026 | Giornaliero |
| IWR · iShares Trust | 0,03% | 462.379 SH | 11 Settembre 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.501.108 SH | 19 Agosto 2026 | Giornaliero |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 19.254 SH | 19 Agosto 2026 | Giornaliero |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 63.630 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.458 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,01% | 48.216 NS | 31 Luglio 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,01% | 25.563 SH | 19 Agosto 2026 | Giornaliero |
| IWD · iShares Trust | 0,01% | 234.063 SH | 11 Settembre 2026 | Giornaliero |
| REVS · Columbia ETF Trust I | 0,01% | 922 NS | 31 Luglio 2026 | N-PORT |
| IWP · iShares Trust | 0,01% | 46.707 SH | 11 Settembre 2026 | Giornaliero |
| ITOT · iShares Trust | 0,01% | 158.911 SH | 11 Settembre 2026 | Giornaliero |
| RECS · Columbia ETF Trust I | 0,01% | 9.430 NS | 31 Luglio 2026 | N-PORT |
| IWB · iShares Trust | 0,00% | 73.105 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 28.131 SH | 10 Settembre 2026 | Giornaliero |
| TILT · FlexShares Trust | 0,00% | 1.106 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 9.683 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.044 NS | 31 Luglio 2026 | N-PORT |
| IWF · iShares Trust | 0,00% | 33.127 SH | 11 Settembre 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,00% | 1.939 NS | 31 Luglio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 6.609 NS | 31 Luglio 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 92.569 SH | 19 Agosto 2026 | Giornaliero |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12.830 SH | 19 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | · | 4.916 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 12.964 SH | 11 Settembre 2026 | Giornaliero |
| SMLF · iShares Trust | · | 40.261 SH | 11 Settembre 2026 | Giornaliero |
VKTX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 26 analisti
COMPRA
Target mediano
$95.00
+217,3%
9 34,6%
Acquisto forte
14 53,8%
Compra
3 11,5%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
19 analisti · 2026-09-30Target medio $94.82 +216,7%
← Sotto tutti i target
Prezzo attuale $29.94
Basso$38.00
Media$94.82
Alto$125.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
| LEGN | · | -26.8 | · | · | -29.1% | · |
| PBLS | · | · | · | · | · | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
Ultime notizie Notizie recenti che menzionano questa società
VKTX Stock Soars as Viking Therapeutics Announces Positive GLP-1 Trial Results
Yahoo Finance · 1 settimana, 2 giorni fa
Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September
Nasdaq · 3 settimane, 1 giorno fa
2 Beaten-Down Stocks With Massive Upside Potential
Nasdaq · 2 mesi, 3 settimane fa
Is Viking Therapeutics Stock a No-Brainer Buy Below $35?
Nasdaq · 3 mesi, 1 settimana fa
Is Viking Therapeutics Stock Going to $100?
Nasdaq · 3 mesi, 3 settimane fa
Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%
Nasdaq · 3 mesi, 3 settimane fa
1 Motivo per cui questo titolo biotech potrebbe triplicare entro fine anno
Nasdaq · 6 mesi fa
Hai $1.500? È Meglio Comprare Bitcoin, o Viking Therapeutics?
Nasdaq · 6 mesi, 1 settimana fa
Cosa sapere su questo sviluppatore di farmaci per l'obesità che ha appena attirato un nuovo investimento di 7 milioni di dollari
Yahoo Finance · 6 mesi, 2 settimane fa
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Lug 29, 2026